Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 289
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00281827 | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | ||
| NCT02525029 | Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD | ||
| NCT03579875 | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT00602693 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | ||
| NCT00748163 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT05973656 | Role of Acetaldehyde in the Development of Oral Cancer | ||
| NCT00290628 | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | ||
| NCT00005993 | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer | ||
| NCT05708924 | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT03421678 | Ethnic/Racial Differences in Metabolism and DNA Adduct Formation | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT00726739 | Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma | ||
| NCT06693986 | Adenovirus (RGDCRAdCOX2F) | ||
| NCT00625729 | Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia | ||
| NCT03998735 | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure | ||
| NCT00889408 | DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma | ||
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT04858594 | Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy | ||
| NCT01400672 | Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma | ||
| NCT06322992 | App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3 | ||
| NCT01560923 | Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer | ||
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
| NCT00176839 | Stem Cell Transplantation for Hematological Malignancies | ||
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer | ||
| NCT01572636 | Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome | ||
| NCT00293293 | Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | ||
| NCT02118311 | Treg Cells for AGVHD in Non-myeloablative UCB Transplant | ||
| NCT00652899 | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | ||
| NCT00668564 | Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism | ||
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders | ||
| NCT00176878 | Stem Cell Transplant for Bone Marrow Failure Syndromes | ||
| NCT00176826 | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders | ||
| NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | ||
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
| NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
| NCT03081780 | Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML | ||
| NCT00356941 | Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC | ||
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT01207076 | AHN-12 Biodistribution in Advanced Leukemia | ||
| NCT00290641 | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | ||
| NCT01171469 | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor |
